Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their ...

The active ingredient in Ozempic and Wegovy was linked to reduced cravings for drinking alcohol among people with alcohol use ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.